Anatara Lifesciences

44 articles about Anatara Lifesciences

• Anatara’s gut-targeted dietary supplement completes preclinical testing, demonstrating it can treat inflammatory gastrointestinal disease and may promote mucosal healing

  10/14/2019

  Successful completion of the preclinical program has provided strong scientific proof that the GaRP dietary supplement has the potential to be game changing

• Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report

  10/31/2018

  Anatara Lifesciences is pleased to release its Appendix 4C for the quarter ending 30th September 2018. The Company's cash position at the end of the quarter stood at $7.1m. 

• Anatara Lifesciences Ltd (ASX:ANR) Formation of Product Development Advisory Board

  10/23/2018

  Anatara Lifesciences to announce the formation of its Product Development Advisory Board.

• Anatara Lifesciences Ltd (ASX:ANR) 2018 Annual Report

  10/10/2018

  Anatara Lifesciences is pleased to release its Annual Report, for the year ended 30th June 2018. 

• Anatara Announces Exclusive Global License Agreement with Zoetis

  5/15/2018

  Agreement represents the achievement of a major milestone for Anatara and its shareholders

• Anatara Lifesciences Presents at Australasian Pig Science Association Conference

  11/21/2017

  A single dose of Detach at weaning was as effective as in-feed ZnO in reducing diarrhoea and antibiotic treatments in piglets post-weaning compared to untreated piglets.

• Anatara Lifesciences Investor Presentation This Week

  10/19/2017

  Anatara Lifesciences is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO - chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.

• Anatara Lifesciences Pork CRC Options Extended By 12 Months

  9/13/2017

• Anatara Lifesciences And Zoetis To Negotiate Terms Of An International Detach Commercial Agreement

  8/21/2017

• Anatara Lifesciences Gold Coast Investment Showcase Investor Presentation

  6/21/2017

• Anatara Lifesciences Wilsons Equity Research Report Issued With Buy Rating

  6/8/2017

• Anatara Lifesciences Investor Update And R&D Tax Rebate

  6/6/2017

• Anatara Lifesciences ABC Video Program - Non-Antibiotic Treatment For Pigs

  3/23/2017

• Anatara Lifesciences Half Yearly Report And Accounts

  2/23/2017

• Anatara Lifesciences Receives Second Payment For Detach Under The Agreement With Zoetis

  1/30/2017

• Anatara Lifesciences Release: Company Research Report 'A Good Gut Feeling' By NDF Research

  1/25/2017

• Anatara Lifesciences Chairman's Address To Shareholders

  11/15/2016

• Anatara Lifesciences AGM Presentation

  11/15/2016

• Anatara Lifesciences Receives R&D Tax Refund

  10/14/2016

• Anatara Lifesciences Annual Report To Shareholders

  10/14/2016